Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis
Melatonin has both pro-inflammatory and anti-inflammatory properties depending on the stage of inflammation. Despite its therapeutic effect in alleviation of some symptoms of multiple sclerosis; the precise role of melatonin in MS pathogenesis remains a topic of debate. The aim of this study was to...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2015-02-01
|
Series: | Iranian Journal of Allergy, Asthma and Immunology |
Subjects: | |
Online Access: | https://ijaai.tums.ac.ir/index.php/ijaai/article/view/407 |
id |
doaj-ca6ee521942b45e2a1667505834fff86 |
---|---|
record_format |
Article |
spelling |
doaj-ca6ee521942b45e2a1667505834fff862020-11-25T04:12:27ZengTehran University of Medical SciencesIranian Journal of Allergy, Asthma and Immunology1735-15021735-52492015-02-01141372Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple SclerosisTaha Gholipour0Taher Ghazizadeh1Sahand Babapour2Behzad Mansouri3Majid Ghafarpour4Bahaadin Siroos5Mohammad Hossein Harirchian6Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran AND Interdisciplinary Neuroscience Research Program, Tehran University of Medical Sciences, Tehran, IranIranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran AND Interdisciplinary Neuroscience Research Program, Tehran University of Medical Sciences, Tehran, IranIranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran AND Interdisciplinary Neuroscience Research Program, Tehran University of Medical Sciences, Tehran, IranSection of Neurology, Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran.Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran.Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran. Melatonin has both pro-inflammatory and anti-inflammatory properties depending on the stage of inflammation. Despite its therapeutic effect in alleviation of some symptoms of multiple sclerosis; the precise role of melatonin in MS pathogenesis remains a topic of debate. The aim of this study was to measure the urine level of one of melatonin products which is an index of serum melatonin level, in MS patients in the acute phase of relapse and control patients. We also analyzed different clinical and cognitive indices in order to find any correlation with melatonin level. Twenty eight patients who were diagnosed as relapsing-remitting MS, according to the revised McDonald criteria, along with 10 age- and sex-matched control subjects were recruited in our study. Here we showed that urine 6-sulphatoxymelatonin levels (aMT6s; the major metabolite of melatonin) were significantly lower in MS patients compared to control group. Interestingly, urine aMT6s levels significantly correlated with MS Functional Composite score, but not Expanded Disability Severity Score. Based on above findings, there might be new hope in developing a quantitative and objective measure to assess the MS severity especially in neurodegenerative diseases. However, our results should be analyzed cautiously. We didn't evaluate simultaneous level of 25-OH Vitamin D. It has been recently reported that there is a negative correlation between melatonin and vitamin D levels. Further studies are needed to confirm this hypothesis.https://ijaai.tums.ac.ir/index.php/ijaai/article/view/407Cognitive FunctionMelatoninMultiple Sclerosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Taha Gholipour Taher Ghazizadeh Sahand Babapour Behzad Mansouri Majid Ghafarpour Bahaadin Siroos Mohammad Hossein Harirchian |
spellingShingle |
Taha Gholipour Taher Ghazizadeh Sahand Babapour Behzad Mansouri Majid Ghafarpour Bahaadin Siroos Mohammad Hossein Harirchian Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis Iranian Journal of Allergy, Asthma and Immunology Cognitive Function Melatonin Multiple Sclerosis |
author_facet |
Taha Gholipour Taher Ghazizadeh Sahand Babapour Behzad Mansouri Majid Ghafarpour Bahaadin Siroos Mohammad Hossein Harirchian |
author_sort |
Taha Gholipour |
title |
Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis |
title_short |
Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis |
title_full |
Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis |
title_fullStr |
Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis |
title_full_unstemmed |
Decreased Urinary Level of Melatonin as a Marker of Disease Severity in Patients with Multiple Sclerosis |
title_sort |
decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis |
publisher |
Tehran University of Medical Sciences |
series |
Iranian Journal of Allergy, Asthma and Immunology |
issn |
1735-1502 1735-5249 |
publishDate |
2015-02-01 |
description |
Melatonin has both pro-inflammatory and anti-inflammatory properties depending on the stage of inflammation. Despite its therapeutic effect in alleviation of some symptoms of multiple sclerosis; the precise role of melatonin in MS pathogenesis remains a topic of debate. The aim of this study was to measure the urine level of one of melatonin products which is an index of serum melatonin level, in MS patients in the acute phase of relapse and control patients. We also analyzed different clinical and cognitive indices in order to find any correlation with melatonin level. Twenty eight patients who were diagnosed as relapsing-remitting MS, according to the revised McDonald criteria, along with 10 age- and sex-matched control subjects were recruited in our study. Here we showed that urine 6-sulphatoxymelatonin levels (aMT6s; the major metabolite of melatonin) were significantly lower in MS patients compared to control group. Interestingly, urine aMT6s levels significantly correlated with MS Functional Composite score, but not Expanded Disability Severity Score. Based on above findings, there might be new hope in developing a quantitative and objective measure to assess the MS severity especially in neurodegenerative diseases. However, our results should be analyzed cautiously. We didn't evaluate simultaneous level of 25-OH Vitamin D. It has been recently reported that there is a negative correlation between melatonin and vitamin D levels. Further studies are needed to confirm this hypothesis. |
topic |
Cognitive Function Melatonin Multiple Sclerosis |
url |
https://ijaai.tums.ac.ir/index.php/ijaai/article/view/407 |
work_keys_str_mv |
AT tahagholipour decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis AT taherghazizadeh decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis AT sahandbabapour decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis AT behzadmansouri decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis AT majidghafarpour decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis AT bahaadinsiroos decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis AT mohammadhosseinharirchian decreasedurinarylevelofmelatoninasamarkerofdiseaseseverityinpatientswithmultiplesclerosis |
_version_ |
1724415414883057664 |